News
The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.
1d
Everyday Health on MSNInvisible Inflammation Is a Stealthy Psoriasis ThreatAbout 1 in 3 people with psoriasis who achieved clear skin with biologic drugs still had underlying inflammation that may contribute to conditions like obesity and heart disease, a new study suggests.
Starjemza (ustekinumab-hmny) was approved by the FDA this week as a biosimilar to Stelara. 2 A pair of clinical trials ...
A study conducted by researchers from the Federal University of São Carlos (UFSCar) found that 72.5% of young Brazilian women ...
2d
Amazon S3 on MSNPsoriasis Symptoms & TreatmentsDr. Jason Rivers, MD, FRCPC, discusses psoriasis symptoms and treatments. Russia, China, North Korea condemn Trump's $175 billion Golden Dome missile shield Pierce Brosnan defends Irish accent in MobL ...
Researchers have found that central body fat, especially around the abdomen, is more strongly linked to psoriasis risk than ...
Women who see doctors for pain from reproductive health conditions are often advised to relax and get help for anxiety ...
Getting a psoriasis diagnosis can be challenging. While there are treatments that can keep your symptoms under control, it may take some trial and error to find the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results